4c-Diagnostics
Home Diagnostic Kit for GI Diseases
Company Overview
Snapshot
Founded in April 2016 by Sharon Ben Yehuda, 4c-Diagnostics operates with 1–10 employees. The company secured one funding round from one investor, MindUP, in September 2018.
Business overview
4c-Diagnostics develops a platform for gastrointestinal disease management, focusing on a hands-free, automatic stool-collection and sampling system. Its core product, the 4C-DiagnosKit, is a three-part module designed for analysis and monitoring of fecal biomarkers, providing diagnostic results within 10 minutes without user involvement. The company operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Digital Medical Diagnostics, serving patients and providers.
Log in to access full profile ›Company Intelligence Q&A
- What is 4c-Diagnostics' primary product?
- 4c-Diagnostics' primary product is the 4C-DiagnosKit, a three-part module for hands-free, automatic stool collection, sample preparation, and diagnostic analysis of fecal biomarkers for gastrointestinal disease management.
- When was 4c-Diagnostics founded?
- 4c-Diagnostics was founded in April 2016.
- Who is the founder of 4c-Diagnostics?
- Sharon Ben Yehuda is the Co-Founder & CEO of 4c-Diagnostics.
- What is the status of 4c-Diagnostics?
- 4c-Diagnostics is currently non-active and ceased to operate in November 2019.